Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Monitor Psychotropic Medication Use

Bossier City, Louisiana Survey Completed on 08-07-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents' drug regimens were free from unnecessary medications by not monitoring for behaviors, effectiveness, or side effects of psychotropic medications for two residents. One resident, with diagnoses including paranoid schizophrenia and major depressive disorder, was prescribed multiple psychotropic medications such as Risperidone, Trazodone, and Mirtazapine. Review of this resident's Medication Administration Records (MAR) for two consecutive months showed no documentation of monitoring for behaviors, effectiveness, or side effects related to these medications. The Director of Nursing confirmed that such monitoring was not performed as required. Another resident, diagnosed with schizoaffective disorder, bipolar disease, and other medical conditions, was prescribed Clonazepam, Olanzapine, and Mirtazapine. Review of the MAR and medical record for this resident also failed to show any monitoring for behaviors or side effects associated with the administration of these psychotropic medications. The Assistant Director of Nursing confirmed the absence of required monitoring for these medications.

An unhandled error has occurred. Reload 🗙